SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Newest WikiLeaks Dump of Clinton Emails Exposes Some Biopharma Chatter
Bio NC
Will the Presidential Election Change the Face of the Way Prescription Drugs are Sold in the United States?
September 23, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Biogen Wants to Go Beyond Drugs, Eyes Medtech
September 23, 2015
 · 
4 min read
Lone Star Bio
McDonald’s Investor Wants It To Cut Antibiotics In All Meats
September 18, 2015
 · 
1 min read
The 5 Most Exciting Biotech Jobs
Biotech Beach
5 Biotech Jobs That Won’t Bore You
September 10, 2015
 · 
3 min read
Cover Letters: Wow The Employer In 30 Seconds Or Less
Biotech Beach
Cover Letters: Wow The Employer In 30 Seconds Or Less
September 10, 2015
 · 
3 min read
Lone Star Bio
Doctors Save Texas Man’s Burned Hand By Sewing It to His Abdomen, Houston Methodist Hospital Reveals
September 9, 2015
 · 
1 min read
Lone Star Bio
This 3D Printed Microscope Could Improve Malaria Diagnosis, Texas A&M University Study
September 4, 2015
 · 
1 min read
Lone Star Bio
Scientists Identify Neuron Responsible For Alcoholism, Texas A&M Health Science Center College Of Medicine Study
September 3, 2015
 · 
4 min read
Lone Star Bio
New BrainHealth Test May Detect Who Is Most At Risk For Alzheimer’s, University of Texas Study
September 1, 2015
 · 
3 min read
Lone Star Bio
Will Wall Street Volatility Dampen The Sizzling Biotech IPO Market?
August 26, 2015
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Press Releases
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
June 24, 2026
 · 
5 min read
Press Releases
Hope Biosciences Reports Positive Published Clinical Data Following Stem Cell Therapy in Chronic Traumatic Brain Injury
June 23, 2026
 · 
2 min read
Press Releases
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
June 23, 2026
 · 
4 min read
Press Releases
Plus Therapeutics to Provide Business Update Call on June 30, 2026
June 23, 2026
 · 
4 min read
Load More